{"DataElement":{"publicId":"7155073","version":"1","preferredName":"Metastatic Diagnosis ISHAK Fibrosis Score Value","preferredDefinition":"A numeric value assigned to indicate the histopathologic degree of liver damage based on a scoring system described by Dr. Ishak.","longName":"7118702v1.0:7114310v1.0","context":"OCCPR","contextVersion":"1","DataElementConcept":{"publicId":"7118702","version":"1","preferredName":"Metastatic Diagnosis ISHAK Fibrosis Score","preferredDefinition":"Any diagnosis indicating the presence of metastatic disease._A scoring system described by Dr. Ishak and colleagues that assesses the histopathologic degree of liver damage.","longName":"6841515v1.0:3182610v1.0","context":"OCCPR","contextVersion":"1","ObjectClass":{"publicId":"6841515","version":"1","preferredName":"Metastatic Diagnosis","preferredDefinition":"Any diagnosis indicating the presence of metastatic disease.","longName":"C162221","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic Diagnosis","conceptCode":"C162221","definition":"Any diagnosis indicating the presence of metastatic disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EFAFAB2-E712-5A45-E053-F662850A0775","latestVersionIndicator":"Yes","beginDate":"2019-07-31","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-07-31","modifiedBy":"ONEDATA","dateModified":"2019-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3182610","version":"1","preferredName":"Ishak Score","preferredDefinition":"A scoring system described by Dr. Ishak and colleagues that assesses the histopathologic degree of liver damage.","longName":"C95149","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ishak Score","conceptCode":"C95149","definition":"A scoring system described by Dr. Ishak and colleagues that assesses the histopathologic degree of liver damage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"99815A97-6CAC-81F1-E040-BB89AD433C8A","latestVersionIndicator":"Yes","beginDate":"2011-01-10","endDate":null,"createdBy":"WHITES","dateCreated":"2011-01-10","modifiedBy":"ONEDATA","dateModified":"2011-01-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9B057235-5619-3BBF-E053-F662850A4C11","latestVersionIndicator":"Yes","beginDate":"2019-12-31","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-31","modifiedBy":"KNABLEJ","dateModified":"2020-02-14","changeDescription":"2/14/20 jk Released per CPTAC SME (Linda) review and approval. 1/29/20 jk upd LN.  12/27/19 jk created for CPTAC CHOL baseline CRF; use term syn.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7114310","version":"1","preferredName":"Ishak Score Value","preferredDefinition":"A scoring system described by Dr. Ishak and colleagues that assesses the histopathologic degree of liver damage._A numerical quantity measured or assigned or computed.","longName":"7114310v1.0","context":"OCCPR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"0 (No Fibrosis)","valueDescription":"Ishak Score 0","ValueMeaning":{"publicId":"3182620","version":"1","preferredName":"Ishak Score 0","longName":"3182620","preferredDefinition":"No evidence of fibrosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ishak Score 0","conceptCode":"C95150","definition":"No evidence of fibrosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9981DDE0-7C2B-AC74-E040-BB89AD4304F4","latestVersionIndicator":"Yes","beginDate":"2011-01-10","endDate":null,"createdBy":"WHITES","dateCreated":"2011-01-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9D4A292D-AA38-4A26-E053-F662850ACC96","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-29","modifiedBy":"ONEDATA","dateModified":"2020-01-29","deletedIndicator":"No"},{"value":"1-2 (Portal Fibrosis)","valueDescription":"Ishak Score 1-2","ValueMeaning":{"publicId":"7114314","version":"1","preferredName":"Ishak Score 1-2","longName":"7114314","preferredDefinition":"Portal fibrosis is present.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ishak Score 1-2","conceptCode":"C157159","definition":"Portal fibrosis is present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9AB2B392-BA54-7E59-E053-F662850AAFB1","latestVersionIndicator":"Yes","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-27","modifiedBy":"ONEDATA","dateModified":"2019-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9D4A292D-AA4C-4A26-E053-F662850ACC96","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-29","modifiedBy":"ONEDATA","dateModified":"2020-01-29","deletedIndicator":"No"},{"value":"3-4 (Fibrous Septa)","valueDescription":"Ishak Score 3-4","ValueMeaning":{"publicId":"7114312","version":"1","preferredName":"Ishak Score 3-4","longName":"7114312","preferredDefinition":"Fibrosis extends beyond the portal areas and bridging fibrosis is present.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ishak Score 3-4","conceptCode":"C157161","definition":"Fibrosis extends beyond the portal areas and bridging fibrosis is present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9AB2B392-BA2C-7E59-E053-F662850AAFB1","latestVersionIndicator":"Yes","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-27","modifiedBy":"ONEDATA","dateModified":"2019-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9D4A292D-AA60-4A26-E053-F662850ACC96","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-29","modifiedBy":"ONEDATA","dateModified":"2020-01-29","deletedIndicator":"No"},{"value":"5 (Nodular Formation and Incomplete Cirrhosis)","valueDescription":"Ishak Score 5","ValueMeaning":{"publicId":"3182617","version":"1","preferredName":"Ishak Score 5","longName":"3182617","preferredDefinition":"Marked bridging fibrosis with formation of occasional hepatic nodules is present.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ishak Score 5","conceptCode":"C95155","definition":"Marked bridging fibrosis with formation of occasional hepatic nodules is present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9981DDE0-7BB8-AC74-E040-BB89AD4304F4","latestVersionIndicator":"Yes","beginDate":"2011-01-10","endDate":null,"createdBy":"WHITES","dateCreated":"2011-01-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9D4A292D-AA74-4A26-E053-F662850ACC96","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-29","modifiedBy":"ONEDATA","dateModified":"2020-01-29","deletedIndicator":"No"},{"value":"6 (Established Cirrhosis)","valueDescription":"Ishak Score 6","ValueMeaning":{"publicId":"3182616","version":"1","preferredName":"Ishak Score 6","longName":"3182616","preferredDefinition":"Marked fibrosis with cirrhosis is present.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ishak Score 6","conceptCode":"C95156","definition":"Marked fibrosis with cirrhosis is present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9981DDE0-7B93-AC74-E040-BB89AD4304F4","latestVersionIndicator":"Yes","beginDate":"2011-01-10","endDate":null,"createdBy":"WHITES","dateCreated":"2011-01-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9D4A292D-AA88-4A26-E053-F662850ACC96","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-29","modifiedBy":"ONEDATA","dateModified":"2020-01-29","deletedIndicator":"No"},{"value":"Unknown: Could not be determined or unsure.","valueDescription":"Indeterminate or Unknown","ValueMeaning":{"publicId":"6841632","version":"1","preferredName":"Indeterminate or Unknown","longName":"6841632","preferredDefinition":"An indication that something is indeterminate or unknown.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Indeterminate or Unknown","conceptCode":"C157157","definition":"An indication that something is indeterminate or unknown.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EFB6B26-0C86-5A31-E053-F662850A5C7D","latestVersionIndicator":"Yes","beginDate":"2019-07-31","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-31","modifiedBy":"ONEDATA","dateModified":"2019-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9AB2B392-BA90-7E59-E053-F662850AAFB1","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-27","modifiedBy":"ONEDATA","dateModified":"2019-12-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7155074","version":"1","preferredName":"Ishak Score Value","preferredDefinition":"A scoring system described by Dr. Ishak and colleagues that assesses the histopathologic degree of liver damage.:A numerical quantity measured or assigned or computed.","longName":"C95149:C25712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ishak Score","conceptCode":"C95149","definition":"A scoring system described by Dr. Ishak and colleagues that assesses the histopathologic degree of liver damage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D48B20B-9B19-3E73-E053-F662850A28E8","latestVersionIndicator":"Yes","beginDate":"2020-01-29","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-29","modifiedBy":"ONEDATA","dateModified":"2020-01-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9AB2B392-B9E3-7E59-E053-F662850AAFB1","latestVersionIndicator":"Yes","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-27","modifiedBy":"KNABLEJ","dateModified":"2020-02-14","changeDescription":"2/14/20 jk Released per CPTAC SME (Linda) review and approval.  1/29/20 jk revised rep term and PVs to match CRF responses.  12/27/19 jk created for CPTAC LIHC and CHOL baseline CRFs.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6601273","version":"1","longName":"CPTAC (Clinical Proteomic Tumor Analysis Consortium)","context":"OCCPR","ClassificationSchemeItems":[{"publicId":"6776762","version":"1","longName":"Bile duct and Liver","context":"OCCPR"},{"publicId":"6779538","version":"1","longName":"CHOL Baseline","context":"OCCPR"},{"publicId":"6779541","version":"1","longName":"LIHC Baseline","context":"OCCPR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"ISHAK Fibrosis Score","type":"Preferred Question Text","description":"ISHAK Fibrosis Score","url":null,"context":"OCCPR"}],"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9D4A299E-3C38-4A2B-E053-F662850A1C47","latestVersionIndicator":"Yes","beginDate":"2020-01-29","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-29","modifiedBy":"KNABLEJ","dateModified":"2020-02-14","changeDescription":"2/14/20 jk Released per CPTAC SME (Linda) review and approval. 1/29/20 jk created for CPTAC LIHC and CHOL baseline CRFs.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}